Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
In two replicate trials, depemokimab, an ultra-long-acting anti–interleukin-5 biologic therapy, reduced exacerbations in patients who had severe asthma with an eosinophilic phenotype.
The New England...
How Does Health Care Burden Patients? Let Me Count the Days
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Gustatory Hyperhidrosis after Parotid Surgery
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Centering the Peripheral Brain — The History of Reference Tools in Medicine
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
